Human SAN–Cardiac Plexus Assembloids Model Pacemaker Maturation

The sinoatrial node (SAN) is the heart’s primary pacemaker, but its behavior cannot be understood from pacemaker cardiomyocytes alone. Intrinsic cardiac neurons influence firing rate, pacemaker dominance, and impulse transmission into the atria. The reference study, Human PSC-derived sinoatrial node-cardiac plexus assembloids model innervation-associated maturation of pacemaker systems, addresses this gap by reconstructing a human neuro-cardiac pacemaker unit in vitro. Its central contribution is not simply the generation of another cardiac organoid, but the assembly of distinct organoid compartments that retain recognizable SAN, neural, and atrial-like identities while permitting functional interaction.

Study Background and Research Question

The SAN occupies a specialized three-dimensional region near the junction of the superior vena cava and right atrium. It contains heterogeneous pacemaker populations, including head, tail, and transitional cells, which collectively support impulse initiation and exit. SAN pacemaker cells are characterized by spontaneous diastolic depolarization and relatively slow-upstroke action potentials, whereas atrial cardiomyocytes are specialized for excitation and conduction rather than primary automaticity.

Animal models have established important principles of SAN development and autonomic regulation, yet species-specific differences in electrophysiology and neural organization complicate direct translation to human biology. Human tissue is also difficult to obtain and analyze because the SAN is small, intramural, and anatomically complex. Human pluripotent stem cell differentiation can produce SAN-like pacemaker cells, but conventional two-dimensional cultures or isolated organoids generally lack the regional organization, cellular heterogeneity, and intrinsic neural inputs present in vivo.

The study therefore asks whether a human pluripotent stem cell-derived model can reproduce three linked properties: a molecularly defined SAN compartment, neural modulation of pacemaker automaticity, and conduction from the SAN toward atrial-like tissue. A second question is mechanistic: can combined functional profiling and spatial transcriptomics reveal a neuron-to-pacemaker signal associated with maturation?

Key Innovation from the Reference Study

The major innovation is the SAN-plexus assembloid. The authors integrate human pluripotent stem cell-derived SAN organoids, termed SANOs, with cardiac ganglionated plexus organoids, or CGPOs. They further incorporate atrial-like cardiac organoids to create a tri-assembloid that models the path from pacemaker impulse generation to atrial activation. This arrangement preserves a degree of tissue-level organization that is not available in a monoculture of SAN-like cardiomyocytes.

This design is valuable because it separates biological roles while allowing direct communication. SANOs provide the pacemaker compartment, CGPOs supply intrinsic cardiac neural cells, and atrial-like organoids provide a downstream excitation target. The resulting system can be assessed at molecular, structural, and electrophysiological levels rather than relying on a single endpoint such as spontaneous beating.

The second innovation is the integration of the assembloid model with spatial transcriptomics of human SAN tissue. Instead of treating organoid gene expression as an isolated catalog, the authors use human spatial information to identify candidate interactions between neuronal and pacemaker populations. Functional analysis then focuses attention on a signaling program in which CGPO-derived prosaposin, abbreviated PSAP, engages the SAN-enriched receptor GPR37. The study links this PSAP–GPR37 interaction with pacemaker maturation, providing a testable molecular explanation for part of the neural influence on SAN development.

Methods and Experimental Design Insights

The experimental logic proceeds from lineage specification to tissue assembly and then to functional interrogation. First, the investigators generate SAN-like cardiac tissue and cardiac plexus organoids from human pluripotent stem cells. The SAN compartment is interpreted in the context of established developmental and molecular features, including pacemaker-associated regulators such as SHOX2, ISL1, and TBX3 and the pacemaker ion channel HCN4. Transitional regions are important because they may retain partial working-myocardium characteristics that support impulse exit toward atrial tissue.

Next, the organoids are brought into physical association. This step is conceptually important: the model does not merely mix neurons and cardiomyocytes, but organizes them into interacting tissue units. The tri-assembloid adds an atrial-like destination, making it possible to examine pacemaker-to-atrial conduction rather than automaticity in isolation. Structural characterization establishes whether the expected compartments form and remain distinguishable after assembly.

Electrophysiological analysis provides the functional test. The study evaluates spontaneous pacemaker behavior, neural modulation of automaticity, and conduction within the assembled system. These measurements are more informative than beat frequency alone because they can distinguish initiation, modulation, and propagation. The platform also supports interrogation of conduction dysfunction associated with disease-relevant phenotypes, although the degree of disease fidelity must be evaluated for each model and differentiation batch.

Finally, spatial transcriptomics of human SAN tissue is combined with assembloid-based functional analysis. This pairing reduces the risk of selecting candidate genes solely because they are differentially expressed in vitro. A spatially localized ligand–receptor relationship becomes more compelling when it is also supported by compartment-specific expression and a corresponding functional phenotype. In this study, that workflow prioritizes PSAP–GPR37 signaling as a candidate neuron-to-pacemaker maturation pathway.

Protocol Parameters

• Cell identity: Confirm SAN, neural, and atrial-like identities before assembly; beating alone is insufficient to establish pacemaker specification.
• Assembly consistency: Standardize organoid developmental stage, size range, contact geometry, and time in co-culture when comparing neural and non-neural conditions.
• Functional baseline: Record spontaneous SAN activity before and after assembly, then assess whether neural inputs alter automaticity or pacemaker-to-atrial propagation.
• Molecular validation: Pair spatial or compartment-resolved transcriptomic data with orthogonal protein or gene-expression measurements for candidate signaling components.
• Mechanistic controls: Use SAN-only, plexus-only, and assembled conditions where appropriate, and interpret PSAP–GPR37 perturbation alongside receptor localization and electrophysiological rescue experiments.

These are design recommendations for reproducing the study’s logic; they should not be mistaken for unreported numerical parameters from the reference paper.

Core Findings and Why They Matter

The resulting SAN-plexus assembloids reproduce molecular, structural, and electrophysiological characteristics relevant to human pacemaker systems, according to the reference study. The model therefore moves beyond an isolated SAN-like cell preparation toward a multicompartment system in which pacemaker activity can be regulated by intrinsic cardiac neural tissue and transmitted to atrial-like tissue.

A key finding is that neural inputs can be functionally interrogated as regulators of SAN automaticity. This creates an experimental distinction between the intrinsic capacity of pacemaker cells to fire and the modulation of that activity by neighboring neurons. Such a distinction is essential for studying heart-rate control and for understanding why a pacemaker phenotype may appear normal in isolation but become dysfunctional when neuro-cardiac communication is impaired.

The tri-assembloid also offers a framework for analyzing conduction. A SAN model that generates spontaneous activity but cannot establish organized exit toward atrial tissue is incomplete as a pacemaker-conduction model. By including atrial-like cardiac organoids, the authors make pacemaker-to-atrial coupling an explicit experimental feature. This is particularly relevant to congenital or acquired disorders in which impulse initiation, exit, and propagation can fail at different points.

The combined spatial and functional analyses identify CGPO-derived PSAP and SAN-enriched GPR37 as a signaling pair associated with pacemaker maturation. The significance lies in the direction of the interaction: neural tissue is presented not only as an acute regulator of firing but also as a source of developmental or maturation-associated information for pacemaker cells. The finding suggests that intrinsic cardiac neurons may help establish the functional state of the SAN, rather than simply responding to an already mature pacemaker network.

More broadly, the work demonstrates how assembloids can be used to connect anatomical organization with mechanism. Spatial transcriptomics supplies tissue context, while organoid assembly supplies experimental access. Together, these approaches provide a rational route for investigating human rhythm development, neuro-cardiac disease mechanisms, and candidate interventions that affect pacemaker maturation or conduction.

Comparison with Existing Internal Articles

The internal article Modeling Human SAN-Neural Interactions Using PSC-Derived Assembloids introduces the same general platform concept: combining PSC-derived SAN and neural organoid technologies to study human heart-rhythm biology. The present reference study adds a more specific experimental architecture by incorporating atrial-like tissue and by linking functional assembloid analysis to spatial transcriptomics from human SAN samples. It also advances the discussion from broad neuro-cardiac interaction toward the PSAP–GPR37 signaling hypothesis.

For literature-focused readers, the relationship between the two resources is therefore complementary. The internal article is useful for orientation and platform-level context, whereas the Cell Stem Cell study should be treated as the primary source for the assembloid design, pacemaker-conduction interpretation, and proposed neuron-to-pacemaker mechanism.

Limitations and Transferability

Assembloids are reductionist models. Even a well-organized SAN-plexus-atrial construct does not reproduce the full heart, including vascular perfusion, mechanical load, circulating endocrine signals, immune interactions, complete autonomic diversity, and long-range conduction anatomy. Organoid differentiation also introduces batch-to-batch variation in cell composition, maturation state, and tissue geometry. These factors can influence spontaneous activity and should be controlled when comparing perturbations.

Spatial transcriptomics can identify anatomically meaningful expression patterns, but expression alone does not establish ligand–receptor causality. The PSAP–GPR37 axis is strengthened by the study’s functional analyses, yet downstream signaling, receptor-specific effects, and the contribution of additional neural factors remain open questions. Further validation in independent human samples and disease-specific assembloid backgrounds would help determine whether the pathway is broadly conserved or restricted to particular pacemaker states.

Why this cross-domain matters, maturity, and limitations

The study is centered on cardiovascular development and pacemaker neurobiology, not oncology. Consequently, it should not be used to infer that a compound developed for JAK2/STAT3 pathway research will alter PSAP–GPR37 signaling, SAN maturation, or cardiac conduction. This boundary is important when adapting the platform to pharmacology: a molecular perturbation can be technically tested in an assembloid, but its relevance must be established through cardiac-specific controls and electrophysiological endpoints rather than inferred from activity in unrelated cancer models.

Thus, transferability is strongest at the level of experimental strategy—building multicellular human models and connecting spatial molecular data to function—not at the level of assuming that mechanisms from another disease area apply to the SAN.

Research Support Resources

Researchers conducting separate oncology experiments can use Cucurbitacin I (SKU A4512), also known as JSI-124, as a pharmacological probe of JAK2/STAT3 signaling. The product information describes applications that include colon cancer cell proliferation inhibition, tumor growth inhibition in vivo, a STAT3 DNA binding inhibition assay, and a cancer cell invasion assay. These workflows belong to cancer research and should not be presented as evidence for the SAN-plexus assembloid mechanism. In the cardiac context, the most defensible use of this platform is to investigate neuro-pacemaker organization, PSAP–GPR37-associated maturation, automaticity, and conduction with appropriately matched controls.